Literature DB >> 27658891

MicroRNA Signatures of Colonic Polyps on Screening and Histology.

Vassiliki L Tsikitis1, Amiee Potter2, Motomi Mori2,3, Julie A Buckmeier4, Christina R Preece4, Christina A Harrington2, Angela N Bartley5, Achyut K Bhattacharyya6, Stanley R Hamilton5, M Peter Lance7, Patricia A Thompson4.   

Abstract

Colorectal cancer and adenoma adjacent to cancer exhibit distinct microRNA (miRNA) alterations in an apparent mucosa-to-adenocarcinoma sequence. The pattern of microRNAs in screen-detected polyps in relation to histologic features and cancer risk has not been investigated. miRNA expression analysis was performed on normal mucosa (NM), hyperplastic polyps (HP), tubular adenomas (TA), tubulovillous adenomas or high-grade dysplasia (TVHG), and serrated polyps [sessile serrated adenoma/polyps (SSA/P) and traditional serrated adenomas (TSA)] in biopsy specimens from 109 patients undergoing screening/surveillance colonoscopy. Generalized linear models were used to identify differentially expressed miRNAs by histologic type and logistic regression to identify miRNA predictors of histopathology. False discovery rate (FDR) was used to control for multiple comparisons. We identified 99 miRNAs differing in at least one of five histopathologic groups (FDR ≤0.05). In a comparison of HPNM versus TVHG, the top most upregulated and downregulated miRNAs in HPNM included miR-145, -143, -107, -194, and -26a (upregulated), and miR-663, -1268, -320b, -1275, and -320b (downregulated; FDR P < 0.05). miR-145 and -619 showed high accuracy to discriminate low- from high-risk polyps without serrated histology (TVHG vs. HPNM + TA; CI, 95.6%), whereas miR-124, -143, and -30a showed high accuracy of separating high-risk polyps (TVHG + TSA) from low-risk polyps (HPNM + TA + SSA/P; CI, 96.0%). For TSAs, miR-125b and -199a were uniquely downregulated relative to HPNMs, and miR-335, -222, and -214 discriminated between non-serrated and serrated histology. Our data support the presence of colorectal cancer-associated miRNA alterations in screen-detected adenomas that may be useful for risk stratification for surveillance interval planning. Cancer Prev Res; 9(12); 942-9. ©2016 AACR. ©2016 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27658891      PMCID: PMC5136314          DOI: 10.1158/1940-6207.CAPR-16-0086

Source DB:  PubMed          Journal:  Cancer Prev Res (Phila)        ISSN: 1940-6215


  41 in total

1.  MicroRNA-30a inhibits epithelial-to-mesenchymal transition by targeting Snai1 and is downregulated in non-small cell lung cancer.

Authors:  Regalla Kumarswamy; Giridhar Mudduluru; Paolo Ceppi; Santoshi Muppala; Miroslaw Kozlowski; Jacek Niklinski; Mauro Papotti; Heike Allgayer
Journal:  Int J Cancer       Date:  2011-08-08       Impact factor: 7.396

Review 2.  Guidelines for colonoscopy surveillance after screening and polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer.

Authors:  David A Lieberman; Douglas K Rex; Sidney J Winawer; Francis M Giardiello; David A Johnson; Theodore R Levin
Journal:  Gastroenterology       Date:  2012-07-03       Impact factor: 22.682

3.  Relevance of miR-21 and miR-143 expression in tissue samples of colorectal carcinoma and its liver metastases.

Authors:  Vlastimil Kulda; Martin Pesta; Ondrej Topolcan; Vaclav Liska; Vladislav Treska; Alan Sutnar; Karel Rupert; Marie Ludvikova; Vaclav Babuska; Lubos Holubec; Radim Cerny
Journal:  Cancer Genet Cytogenet       Date:  2010-07-15

4.  Phase III trial of ursodeoxycholic acid to prevent colorectal adenoma recurrence.

Authors:  David S Alberts; María Elena Martínez; Lisa M Hess; Janine G Einspahr; Sylvan B Green; A K Bhattacharyya; Jose Guillen; Mary Krutzsch; Ashok K Batta; Gerald Salen; Liane Fales; Kris Koonce; Dianne Parish; Mary Clouser; Denise Roe; Peter Lance
Journal:  J Natl Cancer Inst       Date:  2005-06-01       Impact factor: 13.506

5.  MiR-26a inhibits cell growth and tumorigenesis of nasopharyngeal carcinoma through repression of EZH2.

Authors:  Juan Lu; Ming-Liang He; Lu Wang; Ying Chen; Xiong Liu; Qi Dong; Yang-Chao Chen; Ying Peng; Kai-Tai Yao; Hsiang-Fu Kung; Xiang-Ping Li
Journal:  Cancer Res       Date:  2011-01-01       Impact factor: 12.701

6.  Role of anti-oncomirs miR-143 and -145 in human colorectal tumors.

Authors:  Y Akao; Y Nakagawa; I Hirata; A Iio; T Itoh; K Kojima; R Nakashima; Y Kitade; T Naoe
Journal:  Cancer Gene Ther       Date:  2010-01-22       Impact factor: 5.987

7.  MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma.

Authors:  Aaron J Schetter; Suet Yi Leung; Jane J Sohn; Krista A Zanetti; Elise D Bowman; Nozomu Yanaihara; Siu Tsan Yuen; Tsun Leung Chan; Dora L W Kwong; Gordon K H Au; Chang-Gong Liu; George A Calin; Carlo M Croce; Curtis C Harris
Journal:  JAMA       Date:  2008-01-30       Impact factor: 56.272

8.  Genetic changes and histopathological types in colorectal tumors from patients with familial adenomatous polyposis.

Authors:  M Miyaki; M Seki; M Okamoto; A Yamanaka; Y Maeda; K Tanaka; R Kikuchi; T Iwama; T Ikeuchi; A Tonomura
Journal:  Cancer Res       Date:  1990-11-15       Impact factor: 12.701

9.  Morphologic reappraisal of serrated colorectal polyps.

Authors:  Emina Torlakovic; Eva Skovlund; Dale C Snover; Goran Torlakovic; Jahn M Nesland
Journal:  Am J Surg Pathol       Date:  2003-01       Impact factor: 6.394

Review 10.  Serrated polyps and their alternative pathway to the colorectal cancer: a systematic review.

Authors:  Łukasz Szylberg; Marlena Janiczek; Aneta Popiel; Andrzej Marszałek
Journal:  Gastroenterol Res Pract       Date:  2015-04-07       Impact factor: 2.260

View more
  10 in total

1.  Tissue-Specific MicroRNA Expression Patterns in Four Types of Kidney Disease.

Authors:  Maria Angeles Baker; Seth J Davis; Pengyuan Liu; Xiaoqing Pan; Anna Marie Williams; Kenneth A Iczkowski; Sean T Gallagher; Kaylee Bishop; Kevin R Regner; Yong Liu; Mingyu Liang
Journal:  J Am Soc Nephrol       Date:  2017-06-29       Impact factor: 10.121

2.  Discovery and Validation of Circulating Biomarkers of Colorectal Adenoma by High-Depth Small RNA Sequencing.

Authors:  Brian S Roberts; Andrew A Hardigan; Dianna E Moore; Ryne C Ramaker; Angela L Jones; Meredith B Fitz-Gerald; Gregory M Cooper; C Mel Wilcox; Robert P Kimberly; Richard M Myers
Journal:  Clin Cancer Res       Date:  2018-02-28       Impact factor: 12.531

Review 3.  What influences preneoplastic colorectal lesion recurrence?

Authors:  Giulia De Maio; Elisa Zama; Claudia Rengucci; Daniele Calistri
Journal:  Oncotarget       Date:  2017-02-14

Review 4.  MiR-663, a MicroRNA Linked with Inflammation and Cancer That Is under the Influence of Resveratrol.

Authors:  Jean-Jacques Michaille; Victoria Piurowski; Brooke Rigot; Hesham Kelani; Emily C Fortman; Esmerina Tili
Journal:  Medicines (Basel)       Date:  2018-07-09

Review 5.  Colorectal Adenomas-Genetics and Searching for New Molecular Screening Biomarkers.

Authors:  Anna Siskova; Klara Cervena; Jan Kral; Tomas Hucl; Pavel Vodicka; Veronika Vymetalkova
Journal:  Int J Mol Sci       Date:  2020-05-05       Impact factor: 5.923

Review 6.  What could microRNA expression tell us more about colorectal serrated pathway carcinogenesis?

Authors:  Milena Peruhova; Monika Peshevska-Sekulovska; Boris Krastev; Gabriela Panayotova; Viktoriya Georgieva; Rossitza Konakchieva; Georgi Nikolaev; Tsvetelina Veselinova Velikova
Journal:  World J Gastroenterol       Date:  2020-11-14       Impact factor: 5.742

Review 7.  Molecular Features of the Serrated Pathway to Colorectal Cancer: Current Knowledge and Future Directions.

Authors:  Carla Satorres; María García-Campos; Marco Bustamante-Balén
Journal:  Gut Liver       Date:  2021-01-15       Impact factor: 4.519

8.  microRNA-451a regulates colorectal cancer proliferation in response to radiation.

Authors:  Rebecca Ruhl; Shushan Rana; Katherine Kelley; Cristina Espinosa-Diez; Clayton Hudson; Christian Lanciault; Charles R Thomas; V Liana Tsikitis; Sudarshan Anand
Journal:  BMC Cancer       Date:  2018-05-03       Impact factor: 4.430

Review 9.  Novel Diagnostic Biomarkers in Colorectal Cancer.

Authors:  Aneta L Zygulska; Piotr Pierzchalski
Journal:  Int J Mol Sci       Date:  2022-01-13       Impact factor: 5.923

10.  Distinguishing colorectal adenoma from hyperplastic polyp by WNT2 expression.

Authors:  Bangting Wang; Xin Wang; Yujen Tseng; Meina Huang; Feifei Luo; Jun Zhang; Jie Liu
Journal:  J Clin Lab Anal       Date:  2021-09-03       Impact factor: 2.352

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.